13F Insight
DOSSIER · 13F-HR · Q1 2026

Rhenman & Partners Asset Management AB

$810M in tracked AUM across 86 positions as of Q1 2026.

R&
CIK 0001599882 · last filed Mar 31, 2026
Total AUM
$810M
as of Q1 2026
Holdings
86
—
positions
Whale Score
53
53
tracked
Activity
—
no data
changes this Q
AI Analysis · Q1 2026

Rhenman & Partners Asset Management AB filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
BSX
BOSTON SCIENTIFIC CORP
$39M625K4.8%02
REGN
REGENERON PHARMACEUTICALS
$37M48K4.6%03
LLY
LILLY ELI & CO
$31M34K3.8%04
INSM
INSMED INC
$26M160K3.2%05
CVS
CVS HEALTH CORP
$24M337K3.0%06
GILD
GILEAD SCIENCES INC
$23M168K2.9%07
TMO
THERMO FISHER SCIENTIFIC INC
$20M41K2.5%08
BIIB
BIOGEN INC
$20M109K2.5%09
VRTX
VERTEX PHARMACEUTICALS INC
$19M43K2.4%10
ALHC
ALIGNMENT HEALTHCARE INC
$19M1.1M2.3%

Filing history

2026Q1Mar 31
$810M▼ 24.3%
86 positionsView →2025Q4Dec 31
$1.1B▲ 110.6%
94 positionsView →2025Q3Sep 30
$508M▼ 35.8%
60 positionsView →2025Q2Jun 30
$791M▲ 61.0%
90 positionsLocked2025Q1Mar 31
$491M▼ 49.5%
59 positionsLocked2024Q4Dec 31
$973M▼ 21.0%
92 positionsLocked2024Q3Sep 30
$1.2B▲ 18.3%
95 positionsLocked2024Q2Jun 30
$1.0B▼ 1.3%
93 positionsLocked2024Q1Mar 31
$1.1B▲ 5.4%
84 positionsLocked2023Q4Dec 31
$1.0B▲ 7.8%
85 positionsLocked2023Q3Sep 30
$929M▼ 2.1%
82 positionsLocked2023Q2Jun 30
$949M▲ 4.1%
83 positionsLocked
Showing 12 of 44